secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2023-05-22T23:59:59+00:00
Accession:  0001193125-23-149921
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Athira Pharma appoints Andrew Gengos as CFO and CBO; Glenna Mileson retires
---------------------------------------------------------------------------

- Andrew Gengos appointed CFO and CBO effective May 18, 2023, replacing Glenna Mileson who is retiring after eight years.
- Gengos receives $465,000 base salary, 40% bonus target, 400,000 stock options, and 10,000 RSUs tied to LIFT trial milestones.
- Mileson will remain as transitional employee until June 16, 2023, then may serve as consultant at $3,500/month for up to 10 hours.
- Stockholders elected Class III directors Kelly Romano and James Johnson; ratified Ernst & Young as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000119312523149921/0001193125-23-149921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000119312523149921/d457287d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-149921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer